Market overview
The global lacrimal devices market is worth USD 87 mn in 2026 and is forecast to reach USD 141 mn by 2036, growing at a 5.0% CAGR. United States is the largest country market and Punctal plugs is the largest by product segment.
| Scope | Punctal plugs, lacrimal stents and intubation sets used to treat dry eye and blocked tear ducts. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 82 mn |
| Value 2026 | USD 87 mn |
| Value 2036 | USD 141 mn |
| CAGR 2026-2036 | 5.0% |
| Volume 2026 | 2,309 thousand units |
| Volume 2036 | 3,579 thousand units |
| Average price 2026 | USD 37.5 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Lacrimal Devices market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 87 mn |
| 2027 | USD 91 mn |
| 2028 | USD 95 mn |
| 2029 | USD 100 mn |
| 2030 | USD 105 mn |
| 2031 | USD 110 mn |
| 2032 | USD 116 mn |
| 2033 | USD 122 mn |
| 2034 | USD 128 mn |
| 2035 | USD 134 mn |
| 2036 | USD 141 mn |
Lacrimal Devices market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Punctal plugs | 58.0% | 52.3% | USD 50 mn | 3.9% |
| Lacrimal stents and intubation sets | 30.0% | 27.1% | USD 26 mn | 3.9% |
| Drug-eluting punctal inserts | 12.0% | 20.6% | USD 10 mn | 10.8% |
By condition
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Dry eye disease | 64.0% | 67.0% | USD 55 mn | 5.5% |
| Nasolacrimal duct obstruction | 30.0% | 27.2% | USD 26 mn | 4.0% |
| Other lacrimal disorders | 6.0% | 5.7% | USD 5.2 mn | 4.5% |
By material
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Silicone | 52.0% | 48.0% | USD 45 mn | 4.2% |
| Collagen and absorbable | 16.0% | 16.0% | USD 14 mn | 5.0% |
| Acrylic and hydrogel | 20.0% | 22.0% | USD 17 mn | 6.0% |
| Drug-eluting polymers | 12.0% | 14.0% | USD 10 mn | 6.6% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 40.0% | 36.0% | USD 35 mn | 3.9% |
| Ophthalmology clinics | 38.0% | 40.0% | USD 33 mn | 5.5% |
| Ambulatory surgical centres | 22.0% | 24.0% | USD 19 mn | 5.9% |
By duration of use
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Temporary and dissolvable | 34.0% | 36.0% | USD 29 mn | 5.6% |
| Semi-permanent | 30.0% | 30.0% | USD 26 mn | 5.0% |
| Permanent | 36.0% | 34.0% | USD 31 mn | 4.4% |
Top 25 countries for lacrimal devices by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 89.0% of 2026 revenue and the 25 countries below together hold 97.1%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 33 mn | 38.0% | USD 51 mn | 4.5% |
| 2 | Japan | USD 8.7 mn | 10.0% | USD 13 mn | 4.0% |
| 3 | China | USD 8.7 mn | 10.0% | USD 19 mn | 8.0% |
| 4 | Germany | USD 6.1 mn | 7.0% | USD 9.0 mn | 4.1% |
| 5 | United Kingdom | USD 4.3 mn | 5.0% | USD 6.8 mn | 4.6% |
| 6 | France | USD 4.3 mn | 5.0% | USD 6.5 mn | 4.1% |
| 7 | India | USD 3.5 mn | 4.0% | USD 7.2 mn | 7.6% |
| 8 | Italy | USD 3.0 mn | 3.5% | USD 4.5 mn | 4.1% |
| 9 | Brazil | USD 3.0 mn | 3.5% | USD 5.2 mn | 5.6% |
| 10 | South Korea | USD 2.6 mn | 3.0% | USD 4.2 mn | 5.0% |
| 11 | Spain | USD 0.77 mn | 0.9% | USD 1.1 mn | 3.8% |
| 12 | Canada | USD 0.77 mn | 0.9% | USD 1.1 mn | 3.8% |
| 13 | Australia | USD 0.77 mn | 0.9% | USD 1.1 mn | 3.8% |
| 14 | Mexico | USD 0.55 mn | 0.6% | USD 0.99 mn | 6.0% |
| 15 | Turkey | USD 0.55 mn | 0.6% | USD 0.99 mn | 6.0% |
| 16 | Netherlands | USD 0.44 mn | 0.5% | USD 0.63 mn | 3.7% |
| 17 | Russia | USD 0.44 mn | 0.5% | USD 0.63 mn | 3.7% |
| 18 | Taiwan | USD 0.44 mn | 0.5% | USD 0.63 mn | 3.7% |
| 19 | Switzerland | USD 0.44 mn | 0.5% | USD 0.63 mn | 3.7% |
| 20 | Saudi Arabia | USD 0.33 mn | 0.4% | USD 0.59 mn | 6.1% |
| 21 | Poland | USD 0.33 mn | 0.4% | USD 0.48 mn | 3.8% |
| 22 | Belgium | USD 0.33 mn | 0.4% | USD 0.48 mn | 3.8% |
| 23 | Thailand | USD 0.33 mn | 0.4% | USD 0.59 mn | 6.1% |
| 24 | Indonesia | USD 0.33 mn | 0.4% | USD 0.72 mn | 8.1% |
| 25 | Egypt | USD 0.22 mn | 0.2% | USD 0.39 mn | 6.2% |
| Rest of world | USD 2.5 mn | 2.9% | USD 3.5 mn | 3.7% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Ocular Therapeutix
- Beaver-Visitec
- Alcon
Group 2: Regional and specialist players
- FCI Ophthalmics
- Oasis Medical
- Eagle Vision
- Katena Products
- Medennium
- Rumex International
Group 3: Emerging and niche players
- Odyssey Medical
- Mati Therapeutics
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the lacrimal devices market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.0% is calculated from the resulting values.
The market is divided by product, by condition, by material, by end user, by duration of use. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the lacrimal devices market?
The global lacrimal devices market is estimated at USD 82 mn in 2025 and USD 87 mn in 2026.
How fast will the lacrimal devices market grow?
It is forecast to reach USD 141 mn by 2036, a compound annual growth rate of 5.0% from 2026, an increase of USD 54 mn.
Which country is the largest market for lacrimal devices?
United States is the largest market by revenue at USD 33 mn in 2026, 38.0% of the global total. The three largest countries together hold 58.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 8.0% a year from 2026 to 2036.
Which lacrimal devices segment is largest?
In the by product split, Punctal plugs is the largest segment with 58.0% of 2026 revenue.
Who are the leading lacrimal devices companies?
Global leaders include Ocular Therapeutix, Beaver-Visitec, Alcon.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Aquaculture Fungal Infection TreatmentUSD 90 mn · 6.0% CAGR
- Bioabsorbable StentsUSD 92 mn · 7.0% CAGR
- Vaccine CryoprotectantsUSD 81 mn · 8.0% CAGR
- Ostomy Irrigation ProductsUSD 94 mn · 4.3% CAGR
- Brachytherapy Treatment Planning SystemsUSD 95 mn · 5.8% CAGR
- Federated Learning HealthcareUSD 78 mn · 22.0% CAGR
- AI Osteoporosis Screening ToolsUSD 74 mn · 18.0% CAGR
- Emergency Transfer Vacuum MattressUSD 74 mn · 5.0% CAGR
← Laboratory Information Management System Lactation Nutrition Products →